Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H St Clair

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Antioxidants & Redox Signaling|October 8, 2013
Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutasesAaron K Holley, Lu Miao, Daret K St Clair, et al.
Oncology Reports|September 14, 2006
Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivoKristopher R Grimes, Graham W Warren, Fang Fang, et al.
Southern Medical Journal|October 14, 2005
Double balloon GliaSite in the management of recurrent glioblastoma multiformeJames T Payne, William H St Clair, Curtis A Given, et al.
Molecular Cancer Therapeutics|April 8, 2010
RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cellsYong Xu, Fang Fang, Yulan Sun, et al.
Journal of Pediatric Hematology/Oncology|March 7, 2003
Atypical presentation and progression of glioblastoma multiforme in a 6-year-old girl: multidisciplinary case reportChristopher D Jahraus, Megan K Dishop, Sherry L Bayliff, et al.
Cancer Research|March 18, 2010
A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cellsYulan Sun, Daret K St Clair, Yong Xu, et al.
Antioxidants & Redox Signaling|October 8, 2013
Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatmentLu Miao, Aaron K Holley, Yanming Zhao, et al.
Plos One|January 5, 2011
miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymesYong Xu, Fang Fang, Jiayou Zhang, et al.
Molecular Cancer Therapeutics|August 30, 2008
SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiationYong Xu, Fang Fang, Daret K St Clair, et al.
Radiology Case Reports|February 24, 2017
Prostate brachytherapy seed migration to the heart seen on cardiovascular computed tomographic angiographyShilpa Sachdeva, Nneka S Udechukwu, Hossam Elbelasi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Antioxidants & Redox Signaling|October 8, 2013
Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutasesAaron K Holley, Lu Miao, Daret K St Clair, et al.
Oncology Reports|September 14, 2006
Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivoKristopher R Grimes, Graham W Warren, Fang Fang, et al.
Southern Medical Journal|October 14, 2005
Double balloon GliaSite in the management of recurrent glioblastoma multiformeJames T Payne, William H St Clair, Curtis A Given, et al.
Molecular Cancer Therapeutics|April 8, 2010
RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cellsYong Xu, Fang Fang, Yulan Sun, et al.
Journal of Pediatric Hematology/Oncology|March 7, 2003
Atypical presentation and progression of glioblastoma multiforme in a 6-year-old girl: multidisciplinary case reportChristopher D Jahraus, Megan K Dishop, Sherry L Bayliff, et al.
Cancer Research|March 18, 2010
A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cellsYulan Sun, Daret K St Clair, Yong Xu, et al.
Antioxidants & Redox Signaling|October 8, 2013
Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatmentLu Miao, Aaron K Holley, Yanming Zhao, et al.
Plos One|January 5, 2011
miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymesYong Xu, Fang Fang, Jiayou Zhang, et al.
Molecular Cancer Therapeutics|August 30, 2008
SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiationYong Xu, Fang Fang, Daret K St Clair, et al.
Radiology Case Reports|February 24, 2017
Prostate brachytherapy seed migration to the heart seen on cardiovascular computed tomographic angiographyShilpa Sachdeva, Nneka S Udechukwu, Hossam Elbelasi, et al.
Pageof 4